Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Choose the right SP 500 fund for retirement in 2024 by evaluating fees, track record, and diversification.
24,199 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Palantir connects data, software, and decision-making in a way that could reshape enterprise AI. This guide outlines ...
In stock market today, march, Grab surprised investors with a substantial buyback and a bold Foodpanda expansion. Thi...
Is intuitive surgical right now? The robotics leader faces macro headwinds and strong long term demand. This guide br...
Rand Capital's Q1 2026 earnings set the tone for the year. This analysis breaks down the numbers, portfolio quality, ...
If Spirit faces liquidation, the fleet faces a multi-step journey from repossession to resale. Here's a concise brief...
When the AI spotlight faded in April, some top names cooled off just enough to become bargains. This piece breaks dow...
Investors are watching Health Catalyst as healthcare data analytics gain budget priority. This guide breaks down what...
As defense demand accelerates, Anduril Industries partnering with Rocket Lab to tackle hypersonics could reshape fund...
Coca-Cola beat first-quarter 2026 expectations, raised guidance, and signaled margin improvement from an Africa dives...
Brookfield plans value per share offers a long‑term lens on value. This guide explains the metric, how it links to th...
Shopify beat expectations with robust 2025 results, while Amazon posted strong 2026 numbers, underscoring a clear spl...